Cellyan Biotechnology Co., Ltd（HKPD）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-07-16 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-03-27 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-03-18 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-01-16 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-12-31 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-12-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-11-24 | 6-K | CURRENT REPORT | SEC |
| 2025-11-12 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-10-07 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-09-11 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-03-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-01-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。